AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-91
Results: 1-25/91
TUMOR HETEROGENEITY AND EXTREME DRUG-RESISTANCE - MEET YOUR MATCH
Authors: ALBERTS DS
Citation: Ds. Alberts, TUMOR HETEROGENEITY AND EXTREME DRUG-RESISTANCE - MEET YOUR MATCH, The cancer journal from Scientific American, 4(1), 1998, pp. 25-26
DESIGN AND BASE-LINE CHARACTERISTICS OF STUDY PARTICIPANTS IN THE WHEAT BRAN FIBER TRIAL
Authors: MARTINEZ ME REID ME GUILLENRODRIGUEZ J MARSHALL JR SAMPLINER R AICKIN M RITENBAUGH C VANLEEUWEN B MASONLIDDIL N GIULIANO A VARGAS PA ALBERTS DS
Citation: Me. Martinez et al., DESIGN AND BASE-LINE CHARACTERISTICS OF STUDY PARTICIPANTS IN THE WHEAT BRAN FIBER TRIAL, Cancer epidemiology, biomarkers & prevention, 7(9), 1998, pp. 813-816
NUCLEAR MORPHOMETRY IN SOLAR KERATOSIS
Authors: BOZZO PD VAUGHT LC ALBERTS DS THOMPSON D BARTELS PH
Citation: Pd. Bozzo et al., NUCLEAR MORPHOMETRY IN SOLAR KERATOSIS, Analytical and quantitative cytology and histology, 20(1), 1998, pp. 21-28
THE TUMOR PROMOTER DEOXYCHOLIC-ACID INDUCES APOPTOSIS WHILE THE CHEMOPREVENTIVE AGENT URSODEOXYCHOLIC ACID INHIBITS CELL-PROLIFERATION
Authors: MARTINEZ JD STRATAGOULES ED PAYNE CM BATTA AK CRAVEN MT REID M ALBERTS DS POWELL AA POWELL MB EARNEST D
Citation: Jd. Martinez et al., THE TUMOR PROMOTER DEOXYCHOLIC-ACID INDUCES APOPTOSIS WHILE THE CHEMOPREVENTIVE AGENT URSODEOXYCHOLIC ACID INHIBITS CELL-PROLIFERATION, Gastroenterology, 114(4), 1998, pp. 1615-1615
TREATMENT WITH 600 MG DAY OF URSODEOXYCHOLIC ACID MAXIMALLY SUPPRESSES THE PROPORTION OF DEOXCHOLIC ACID IN FECAL WATER/
Authors: EARNEST DL REID M HEDDENS D BATTA AK SALEN G ALBERTS DS MORALES T
Citation: Dl. Earnest et al., TREATMENT WITH 600 MG DAY OF URSODEOXYCHOLIC ACID MAXIMALLY SUPPRESSES THE PROPORTION OF DEOXCHOLIC ACID IN FECAL WATER/, Gastroenterology, 114(4), 1998, pp. 2413-2413
PRIMARY PREVENTION OF COLON-CANCER WITH DIETARY AND MICRONUTRIENT INTERVENTIONS
Authors: ALBERTS DS SLATTERY ML GIOVANNUCCI E SHIKE M GARCIA DJ
Citation: Ds. Alberts et al., PRIMARY PREVENTION OF COLON-CANCER WITH DIETARY AND MICRONUTRIENT INTERVENTIONS, Cancer, 83(8), 1998, pp. 1734-1739
CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS
Authors: AABO K ADAMS M ADNITT P ALBERTS DS ATHANAZZIOU A BARLEY V BELL DR BIANCHI U BOLIS G BRADY MF BRODOVSKY HS BRUCKNER H BUYSE M CANETTA R CHYLAK V COHEN CJ COLOMBO N CONTE PF CROWTHER D EDMONSON JH GENNATAS C GILBEY E GORE M GUTHRIE D KAYE SB LAING AH LANDONI F LEONARD RC LEWIS C LIU PY MANGIONI C MARSONI S MEERPOHL H OMURA GA PARMAR MKB PATER J PECORELLI S PRESTI M SAUERBREI W SKARLOS DV SMALLEY RV SOLOMON HJ STEWART LA STURGEON JFG TATTERSALL MHN WHARTON JT HUININK WWT TOMIROTTI M TORRI W TROPE C TURBOW MM VERMORKEN JB WEBB MJ WILBUR DW WILLIAMS CJ WILTSHAW E YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
ASSOCIATION BETWEEN CIGARETTE-SMOKING AND K-RAS MUTATIONS IN COLORECTAL ADENOMAS
Authors: MARTINEZ ME MATZMAN T MARSHALL JR EINSPAHR J REID M GUILLENRODRIGUEZ J VANLEEUWEN B AHNEN DJ ALBERTS DS
Citation: Me. Martinez et al., ASSOCIATION BETWEEN CIGARETTE-SMOKING AND K-RAS MUTATIONS IN COLORECTAL ADENOMAS, American journal of epidemiology, 147(11), 1998, pp. 276-276
EXPRESSION OF P53 PROTEIN IN ACTINIC KERATOSIS, ADJACENT, NORMAL-APPEARING, AND NON-SUN-EXPOSED HUMAN SKIN
Authors: EINSPAHR J ALBERTS DS AICKIN M WELCH K BOZZO P GROGAN T NELSON M
Citation: J. Einspahr et al., EXPRESSION OF P53 PROTEIN IN ACTINIC KERATOSIS, ADJACENT, NORMAL-APPEARING, AND NON-SUN-EXPOSED HUMAN SKIN, Cancer epidemiology, biomarkers & prevention, 6(8), 1997, pp. 583-587
USE OF A FOOD FREQUENCY QUESTIONNAIRE TO SCREEN FOR DIETARY ELIGIBILITY IN A RANDOMIZED CANCER PREVENTION PHASE-III TRIAL
Authors: RITENBAUGH C AICKIN M TAREN D TEUFEL N GRAVER E WOOLF K ALBERTS DS
Citation: C. Ritenbaugh et al., USE OF A FOOD FREQUENCY QUESTIONNAIRE TO SCREEN FOR DIETARY ELIGIBILITY IN A RANDOMIZED CANCER PREVENTION PHASE-III TRIAL, Cancer epidemiology, biomarkers & prevention, 6(5), 1997, pp. 347-354
THE EFFECT OF WHEAT BRAN FIBER AND CALCIUM SUPPLEMENTATION ON RECTAL MUCOSAL PROLIFERATION RATES IN PATIENTS WITH RESECTED ADENOMATOUS COLORECTAL POLYPS
Authors: ALBERTS DS EINSPAHR J RITENBAUGH C AICKIN M REESMCGEE S ATWOOD J EMERSON S MASONLIDDIL N BETTINGER L PATEL J BELLAPRAVALU S RAMANUJAM PS PHELPS J CLARK L
Citation: Ds. Alberts et al., THE EFFECT OF WHEAT BRAN FIBER AND CALCIUM SUPPLEMENTATION ON RECTAL MUCOSAL PROLIFERATION RATES IN PATIENTS WITH RESECTED ADENOMATOUS COLORECTAL POLYPS, Cancer epidemiology, biomarkers & prevention, 6(3), 1997, pp. 161-169
EFFECT OF RETINOL IN PREVENTING SQUAMOUS-CELL SKIN-CANCER IN MODERATE-RISK SUBJECTS - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL
Authors: MOON TE LEVINE N CARTMEL B BANGERT JL RODNEY S DONG Q PENG YM ALBERTS DS
Citation: Te. Moon et al., EFFECT OF RETINOL IN PREVENTING SQUAMOUS-CELL SKIN-CANCER IN MODERATE-RISK SUBJECTS - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL, Cancer epidemiology, biomarkers & prevention, 6(11), 1997, pp. 949-956
TRIAL OF RETINOL AND ISOTRETINOIN IN SKIN-CANCER PREVENTION - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL
Authors: LEVINE N MOON TE CARTMEL B BANGERT JL RODNEY S DONG Q PENG YM ALBERTS DS
Citation: N. Levine et al., TRIAL OF RETINOL AND ISOTRETINOIN IN SKIN-CANCER PREVENTION - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL, Cancer epidemiology, biomarkers & prevention, 6(11), 1997, pp. 957-961
SURROGATE END-POINT BIOMARKERS AS MEASURES OF COLON-CANCER RISK AND THEIR USE IN CANCER CHEMOPREVENTION TRIALS
Authors: EINSPAHR JG ALBERTS DS GAPSTUR SM BOSTICK RM EMERSON SS GERNER EW
Citation: Jg. Einspahr et al., SURROGATE END-POINT BIOMARKERS AS MEASURES OF COLON-CANCER RISK AND THEIR USE IN CANCER CHEMOPREVENTION TRIALS, Cancer epidemiology, biomarkers & prevention, 6(1), 1997, pp. 37-48
IN-VITRO PHASE-II COMPARISON OF THE CYTOTOXICITY OF A NOVEL PLATINUM ANALOG, NEDAPLATIN (254-S), WITH THAT OF CISPLATIN AND CARBOPLATIN AGAINST FRESH, HUMAN OVARIAN CANCERS
Authors: ALBERTS DS FANTA PT RUNNING KL ADAIR LP GARCIA DJ LIUSTEVENS R SALMON SE
Citation: Ds. Alberts et al., IN-VITRO PHASE-II COMPARISON OF THE CYTOTOXICITY OF A NOVEL PLATINUM ANALOG, NEDAPLATIN (254-S), WITH THAT OF CISPLATIN AND CARBOPLATIN AGAINST FRESH, HUMAN OVARIAN CANCERS, Cancer chemotherapy and pharmacology, 39(6), 1997, pp. 493-497
PHASE-II EVALUATION OF TOPOTECAN IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP TRIAL (SWOG-9241)
Authors: MACDONALD JS BENEDETTI JK MODIANO M ALBERTS DS
Citation: Js. Macdonald et al., PHASE-II EVALUATION OF TOPOTECAN IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP TRIAL (SWOG-9241), Investigational new drugs, 15(4), 1997, pp. 357-359
BAND 1P36 ABNORMALITIES AND T(1-17) IN OVARIAN-CARCINOMA
Authors: THOMPSON FH TAETLE R TRENT JM LIU Y MASSEYBROWN K SCOTT KM WEINSTEIN RS EMERSON JC ALBERTS DS NELSON MA
Citation: Fh. Thompson et al., BAND 1P36 ABNORMALITIES AND T(1-17) IN OVARIAN-CARCINOMA, Cancer genetics and cytogenetics, 96(2), 1997, pp. 106-110
TREATMENT OF OVARIAN-CANCER WITH INTRAPERITONEAL CISPLATIN - REPLY
Authors: ALBERTS DS
Citation: Ds. Alberts, TREATMENT OF OVARIAN-CANCER WITH INTRAPERITONEAL CISPLATIN - REPLY, The New England journal of medicine, 336(23), 1997, pp. 1675-1675
1,4-DISUBSTITUTED ANTHRACENE ANTITUMOR AGENTS
Authors: IYENGAR BS DORR RT ALBERTS DS SOLYOM AM KRUTZSCH M REMERS WA
Citation: Bs. Iyengar et al., 1,4-DISUBSTITUTED ANTHRACENE ANTITUMOR AGENTS, Journal of medicinal chemistry, 40(23), 1997, pp. 3734-3738
1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES WITH SUBSTITUENTS AT POSITION-4, POSITION-8, POSITION-9, POSITION-10, AND POSITION-11 - SYNTHESIS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS (VOL 39, PG 4978, 1996)
Authors: SAMI SM DORR RT ALBERTS DS SOLYOM AM REMERS WA
Citation: Sm. Sami et al., 1,2-DIHYDRO-3H-DIBENZ[DE,H]ISOQUINOLINE-1,3-DIONES WITH SUBSTITUENTS AT POSITION-4, POSITION-8, POSITION-9, POSITION-10, AND POSITION-11 - SYNTHESIS, ANTITUMOR-ACTIVITY, AND QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS (VOL 39, PG 4978, 1996), Journal of medicinal chemistry, 40(16), 1997, pp. 2660-2660
SULINDAC INDUCES REGRESSION AND PREVENTS PROGRESSION OF SPORADIC COLORECTAL ADENOMAS
Authors: DISARIO JA ALBERTS DS TIETZE CC KHULLAR SK BOHMAN VD LARSEN BR HIXSON LJ SAMOWITZ WS READING JC BUYS SS DAWSON R BURT RW
Citation: Ja. Disario et al., SULINDAC INDUCES REGRESSION AND PREVENTS PROGRESSION OF SPORADIC COLORECTAL ADENOMAS, Gastroenterology, 112(4), 1997, pp. 555-555
SAFETY ASPECTS OF PEGYLATED LIPOSOMAL DOXORUBICIN IN PATIENTS WITH CANCER
Authors: ALBERTS DS GARCIA DJ
Citation: Ds. Alberts et Dj. Garcia, SAFETY ASPECTS OF PEGYLATED LIPOSOMAL DOXORUBICIN IN PATIENTS WITH CANCER, Drugs, 54, 1997, pp. 30-35
SULINDAC SULFONE INHIBITS AZOXYMETHANE-INDUCED COLON CARCINOGENESIS IN RATS WITHOUT REDUCING PROSTAGLANDIN LEVELS
Authors: PIAZZA GA ALBERTS DS HIXSON LJ PARANKA NS LI H FINN T BOGERT C GUILLEN JM BRENDEL K GROSS PH SPERL G RITCHIE J BURT RW ELLSWORTH L AHNEN DJ PAMUKCU R
Citation: Ga. Piazza et al., SULINDAC SULFONE INHIBITS AZOXYMETHANE-INDUCED COLON CARCINOGENESIS IN RATS WITHOUT REDUCING PROSTAGLANDIN LEVELS, Cancer research, 57(14), 1997, pp. 2909-2915
COLON-CANCER REDUCTION - QUESTIONS ABOUT IMPLEMENTATION OF PROVEN TECHNIQUES
Authors: MARSHALL JR ALBERTS DS SAMPLINER RE
Citation: Jr. Marshall et al., COLON-CANCER REDUCTION - QUESTIONS ABOUT IMPLEMENTATION OF PROVEN TECHNIQUES, Archives of internal medicine, 157(17), 1997, pp. 1919-1920
RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF EFFECT OF WHEAT BRAN FIBER AND CALCIUM ON FECAL BILE-ACIDS IN PATIENTS WITH RESECTED ADENOMATOUS COLON POLYPS
Authors: ALBERTS DS RITENBAUGH C STORY JA AICKIN M REESMCGEE S BULLER MK ATWOOD J PHELPS J RAMANUJAM PS BELLAPRAVALU S PATEL J BETTINGER L CLARK L
Citation: Ds. Alberts et al., RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF EFFECT OF WHEAT BRAN FIBER AND CALCIUM ON FECAL BILE-ACIDS IN PATIENTS WITH RESECTED ADENOMATOUS COLON POLYPS, Journal of the National Cancer Institute, 88(2), 1996, pp. 81-92
Risultati: 1-25 | 26-50 | 51-75 | 76-91